Literature DB >> 18661516

Admission international normalized ratio and acute infarct volume in ischemic stroke.

Hakan Ay1, Ethem Murat Arsava, Levent Gungor, David Greer, Aneesh B Singhal, Karen L Furie, Walter J Koroshetz, A Gregory Sorensen.   

Abstract

OBJECTIVE: The level of anticoagulation at the time of stroke onset may influence the size, composition, and dissolution rate of the occlusive clot. We explored the relation between admission international normalized ratio (INR) and acute infarct volume in patients with ischemic stroke.
METHODS: We studied 93 consecutive patients with preadmission warfarin use who had INR measurement and diffusion-weighted imaging performed within 24 hours of stroke onset. Ninety-three etiologic stroke subtype-matched patients without prior warfarin use served as control patients. Linear regression analysis was used to test for independence of INR as a predictor of infarct volume.
RESULTS: In patients with preadmission warfarin use, admission INR was inversely correlated with lesion volume on diffusion-weighted imaging (r = -0.38). This relation was retained after adjustment for potential covariates (p = 0.014). INR less than 2.0 was associated with 3.5-fold (95% confidence interval, 2.9-4.2) greater lesion volume on diffusion-weighted imaging as compared with INR of 2.0 or more. Patients who were on therapeutic INR (>or=2.0) had smaller infarcts compared with patients without preadmission warfarin use (p = 0.001). Admission INR was inversely correlated with acute perfusion defect (r = -0.33), chronic infarct volume (r = -0.42), National Institutes of Health Stroke Scale score at admission (r = -0.27), and modified Rankin score at discharge (r = -0.28).
INTERPRETATION: These results suggest that preadmission warfarin use associated with therapeutic level of anticoagulation can offer a benefit in limiting the extent of ischemic injury in an event of acute stroke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661516     DOI: 10.1002/ana.21456

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Reduced Ischemic Lesion Growth with Heparin in Acute Ischemic Stroke.

Authors:  Eva A Rocha; Ruijun Ji; Hakan Ay; Zixiao Li; Ethem Murat Arsava; Gisele S Silva; Alma Gregory Sorensen; Ona Wu; Aneesh B Singhal
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-03-29       Impact factor: 2.136

2.  Stroke Lesions in a Large Upper Limb Rehabilitation Trial Cohort Rarely Match Lesions in Common Preclinical Models.

Authors:  Matthew A Edwardson; Ximing Wang; Brent Liu; Li Ding; Christianne J Lane; Caron Park; Monica A Nelsen; Theresa A Jones; Steven L Wolf; Carolee J Winstein; Alexander W Dromerick
Journal:  Neurorehabil Neural Repair       Date:  2017-01-01       Impact factor: 3.919

3.  Effect of anticoagulation on cardioembolic stroke severity, outcomes and response to intravenous thrombolysis.

Authors:  Ignacio Illán-Gala; Patricia Martínez-Sánchez; Blanca Fuentes; Yudy Llamas-Osorio; Javier Díaz de Terán; Melissa Báez; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; Manuel Lara-Lara; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

4.  Diffusion-weighted ASPECTS as an independent marker for predicting functional outcome.

Authors:  Hideaki Tei; Sinichiro Uchiyama; Toru Usui; Kuniko Ohara
Journal:  J Neurol       Date:  2010-10-19       Impact factor: 4.849

Review 5.  Admission Severity of Atrial-Fibrillation-Related Acute Ischemic Stroke in Patients under Anticoagulation Treatment: A Systematic Review and Meta-Analysis.

Authors:  Catarina Garcia; Marcelo Silva; Mariana Araújo; Mariana Henriques; Marta Margarido; Patrícia Vicente; Hipólito Nzwalo; Ana Macedo
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

6.  Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.

Authors:  Shadi Yaghi; Ava L Liberman; Nils Henninger; Brian Mac Grory; Amre Nouh; Erica Scher; James Giles; Angela Liu; Muhammad Nagy; Ashutosh Kaushal; Idrees Azher; Hiba Fakhri; Kiersten Brown Espaillat; Syed Daniyal Asad; Hemanth Pasupuleti; Heather Martin; Jose Tan; Manivannan Veerasamy; Charles Esenwa; Natalie Cheng; Khadean Moncrieffe; Iman Moeini-Naghani; Mithilesh Siddu; Tushar Trivedi; Koto Ishida; Jennifer Frontera; Aaron Lord; Karen Furie; Salah Keyrouz; Adam de Havenon; Eva Mistry; Christopher R Leon Guerrero; Muhib Khan
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-13       Impact factor: 2.136

7.  Molecular biomarkers in stroke diagnosis and prognosis.

Authors:  Matthew B Maas; Karen L Furie
Journal:  Biomark Med       Date:  2009-08-01       Impact factor: 2.851

8.  The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach.

Authors:  Semi Oh; Suk Jae Kim; Soo-Kyoung Ryu; Gyeong-Moon Kim; Chin Sang Chung; Kwang Ho Lee; Oh Young Bang
Journal:  BMC Neurol       Date:  2011-08-24       Impact factor: 2.474

9.  Predictors of poor outcome in patients with acute cerebral infarction.

Authors:  Nobuhiro Dougu; Shutaro Takashima; Etsuko Sasahara; Yoshiharu Taguchi; Shigeo Toyoda; Tadakazu Hirai; Takashi Nozawa; Kortaro Tanaka; Hiroshi Inoue
Journal:  J Clin Neurol       Date:  2011-12-29       Impact factor: 3.077

10.  Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.

Authors:  Yun Kyung Park; Mi Ji Lee; Jae Ha Kim; Suk Jae Kim; June Soo Kim; Soo-Youn Lee; Oh Young Bang
Journal:  J Stroke       Date:  2015-05-29       Impact factor: 6.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.